Bank Julius Baer & Co. Ltd Zurich Lowers Stock Holdings in UiPath Inc. (NYSE:PATH)

Bank Julius Baer & Co. Ltd Zurich lowered its holdings in UiPath Inc. (NYSE:PATHFree Report) by 62.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 5,537 shares of the healthcare company’s stock after selling 9,325 shares during the period. Bank Julius Baer & Co. Ltd Zurich’s holdings in UiPath were worth $138,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. HighMark Wealth Management LLC acquired a new position in UiPath in the fourth quarter valued at $27,000. Fifth Third Bancorp boosted its holdings in UiPath by 2,005.3% in the third quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock valued at $34,000 after acquiring an additional 1,905 shares during the last quarter. GAMMA Investing LLC acquired a new position in UiPath in the fourth quarter valued at $36,000. FNY Investment Advisers LLC acquired a new position in UiPath in the fourth quarter valued at $40,000. Finally, FSC Wealth Advisors LLC acquired a new position in UiPath in the fourth quarter valued at $43,000. Hedge funds and other institutional investors own 62.50% of the company’s stock.

UiPath Stock Up 0.3 %

Shares of NYSE PATH opened at $19.46 on Monday. UiPath Inc. has a 1 year low of $12.38 and a 1 year high of $27.87. The stock’s 50-day simple moving average is $22.19 and its 200-day simple moving average is $21.61.

UiPath (NYSE:PATHGet Free Report) last announced its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The business had revenue of $405.25 million for the quarter, compared to analyst estimates of $383.32 million. Research analysts forecast that UiPath Inc. will post -0.04 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PATH has been the topic of a number of research analyst reports. William Blair initiated coverage on UiPath in a report on Tuesday, January 2nd. They issued an “outperform” rating on the stock. KeyCorp assumed coverage on UiPath in a research note on Monday, April 8th. They set an “overweight” rating and a $27.00 price objective on the stock. Mizuho boosted their price objective on UiPath from $22.00 to $25.00 and gave the stock a “neutral” rating in a research note on Thursday, March 14th. Scotiabank boosted their price objective on UiPath from $29.00 to $30.00 and gave the stock a “sector perform” rating in a research note on Thursday, March 14th. Finally, Canaccord Genuity Group boosted their price objective on UiPath from $27.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, March 15th. Nine equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, UiPath currently has an average rating of “Moderate Buy” and an average target price of $27.41.

Read Our Latest Research Report on PATH

Insider Activity at UiPath

In related news, CFO Ashim Gupta sold 16,000 shares of the business’s stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $22.84, for a total value of $365,440.00. Following the completion of the sale, the chief financial officer now directly owns 87,505 shares of the company’s stock, valued at $1,998,614.20. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders sold a total of 72,000 shares of company stock valued at $1,591,360 over the last three months. 31.03% of the stock is owned by insiders.

UiPath Company Profile

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Further Reading

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATHFree Report).

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.